Galaxy Surfactants Ltd is Rated Sell

2 hours ago
share
Share Via
Galaxy Surfactants Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Galaxy Surfactants Ltd is Rated Sell

Current Rating and Its Significance

MarketsMOJO currently assigns Galaxy Surfactants Ltd a 'Sell' rating, reflecting a cautious stance on the stock. This rating indicates that, based on a comprehensive evaluation of the company’s quality, valuation, financial trends, and technical indicators, the stock is expected to underperform relative to the broader market or its sector peers. Investors should consider this recommendation as a signal to review their exposure to the stock carefully and weigh potential risks against rewards.

Rating Update Context

The 'Sell' rating was established on 01 Jan 2026, following an improvement from a previous 'Strong Sell' grade. This change was accompanied by a notable increase in the Mojo Score from 28 to 42 points, signalling a modest improvement in the company’s overall assessment. Despite this upgrade, the current rating remains negative, underscoring ongoing concerns about the stock’s prospects.

Here’s How Galaxy Surfactants Looks Today

As of 11 May 2026, the stock’s performance and financial indicators present a mixed picture. The company’s market capitalisation remains in the smallcap segment within the Specialty Chemicals sector. Recent price movements show a 1-day decline of 2.31%, with a modest 1-month gain of 2.62%, but longer-term returns remain subdued. Over the past six months, the stock has declined by 16.31%, and year-to-date returns stand at -8.08%. The one-year return is negative at -9.56%, reflecting persistent challenges in generating shareholder value.

Quality Assessment

Galaxy Surfactants holds a 'good' quality grade, indicating a stable operational foundation and reasonable business fundamentals. However, the company’s long-term growth has been disappointing, with operating profit shrinking at an annualised rate of -0.33% over the last five years. The latest half-year results reveal flat performance, with key efficiency metrics such as Return on Capital Employed (ROCE) at a low 13.57% and inventory turnover ratio at 5.82 times, both among the lowest in recent periods. Earnings per share (EPS) for the quarter stands at Rs 16.63, signalling limited earnings momentum.

Valuation Considerations

Valuation remains a significant concern, with the stock graded as 'very expensive'. The price-to-book value ratio is elevated at 2.7, suggesting the market is pricing the stock at a premium relative to its net asset value. This premium is not fully supported by the company’s financial performance, as reflected in a Return on Equity (ROE) of 11.3%. Over the past year, profits have declined by 5.3%, while the stock price has fallen by 6.94%, indicating that the valuation premium may be unjustified given the earnings contraction.

Financial Trend Analysis

The financial trend for Galaxy Surfactants is classified as 'flat', highlighting a lack of significant growth or deterioration in recent periods. The company’s operating results have remained largely stagnant, with no clear upward trajectory in profitability or efficiency. This stagnation is a key factor influencing the cautious rating, as investors typically seek companies demonstrating consistent financial improvement.

Technical Outlook

From a technical perspective, the stock is rated as 'mildly bearish'. Recent price action shows volatility and a downward bias, with the stock underperforming the BSE500 benchmark consistently over the last three years. This persistent underperformance, combined with negative returns in multiple annual periods, suggests limited near-term upside from a market momentum standpoint.

Comparative Performance and Market Position

Galaxy Surfactants has consistently lagged behind its benchmark indices and peers. The stock’s underperformance over the past three years, coupled with declining profits and expensive valuation, reinforces the rationale behind the 'Sell' rating. Investors should be mindful that the stock’s premium valuation is not currently supported by robust earnings growth or operational improvements.

Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!

  • - Fresh momentum detected
  • - Explosive short-term signals
  • - Early wave positioning

Catch the Wave Now →

What This Rating Means for Investors

The 'Sell' rating on Galaxy Surfactants Ltd advises investors to exercise caution. It reflects a combination of factors including subdued growth prospects, expensive valuation, flat financial trends, and a mildly bearish technical outlook. For investors, this suggests that the stock may face headwinds in delivering attractive returns in the near to medium term. Portfolio managers and individual investors should consider this rating in the context of their risk tolerance and investment horizon, potentially favouring more compelling opportunities within the specialty chemicals sector or broader market.

Summary of Key Metrics as of 11 May 2026

To summarise, the latest data shows:

  • Mojo Score: 42.0, corresponding to a 'Sell' grade
  • Operating profit growth over 5 years: -0.33% annualised
  • ROCE (Half Year): 13.57%, among the lowest recently
  • Inventory Turnover Ratio (Half Year): 5.82 times
  • EPS (Quarterly): Rs 16.63
  • Price to Book Value: 2.7, indicating a very expensive valuation
  • ROE: 11.3%
  • Stock returns over 1 year: -9.56%
  • Consistent underperformance against BSE500 over 3 years

These metrics collectively underpin the current 'Sell' rating and provide a comprehensive view of the stock’s standing in today’s market environment.

Looking Ahead

Investors should monitor upcoming quarterly results and sector developments closely. Any significant improvement in profitability, valuation rationalisation, or positive technical signals could warrant a reassessment of the stock’s outlook. Until then, the cautious stance remains justified based on the current evidence.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News